Skip to main content

Table 2 Person-days and crude incidence rates of diabetes among initiators of angiotensin receptor blockers

From: Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study

  Losartan Valsartan Irbesartan Candesartan Telmisartan Olmesartan
Exposed person-days 160,956,721 252,964,999 115,243,240 44,349,122 46,800,437 26,163,756
Mean follow-up days 1263.57 1378.66 1425.48 1124.76 1336.51 992.22
Mean treatment duration (days) 312.03 349.32 379.50 344.67 329.76 271.00
Mean daily dosage (DDD) 0.36 0.39 0.39 0.41 0.42 0.37
Number of newly diagnosed diabetes 16,227 25,849 11,436 4,371 4,666 2,809
Crude incidence rate per 1,000,000 person-days (95% CI) 100.82 (99.26-102.37) 102.18 (100.94-103.43) 99.23 (97.41-101.05) 98.56 (95.64-101.48) 99.70 (96.84-102.56) 107.36 (103.39-111.33)